Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

KRYS holding history

Krystal Biotech, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KRYS overviewAll 13F holders of KRYSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q2 2021
Holdings of KRYS by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−996−100.0%Sold outHolders
Q1 2026996$257.3K<0.1%−1,112−52.8%ReducedHolders
Q4 20252,108$519.7K<0.1%−4,706−69.1%ReducedHolders
Q3 20256,814$1.20M<0.1%−4,913−41.9%ReducedHolders
Q2 202511,727$1.61M<0.1%−38,165−76.5%ReducedHolders
Q1 202549,892$9.00M<0.1%+42,465+571.8%AddedHolders
Q4 20247,427$1.16M<0.1%−1,919−20.5%ReducedHolders
Q3 20249,346$1.70M<0.1%−1,700−15.4%ReducedHolders
Q2 202411,046$2.03M<0.1%−70,981−86.5%ReducedHolders
Q1 202482,027$14.6M<0.1%+14,886+22.2%AddedHolders
Q4 202367,141$8.33M<0.1%+11,384+20.4%AddedHolders
Q3 202355,757$6.47M<0.1%+45,962+469.2%AddedHolders
Q2 20239,795$1.15M<0.1%+4,200+75.1%AddedHolders
Q1 20235,595$447.9K<0.1%−805−12.6%ReducedHolders
Q4 20226,400$507.0K<0.1%−1,700−21.0%ReducedHolders
Q3 20228,100$565.0K<0.1%00.0%UnchangedHolders
Q2 20228,100$532.0K<0.1%+4,291+112.7%AddedHolders
Q1 20223,809$253.0K<0.1%+3,809NewHolders
Q4 20210$00.0%−13,571−100.0%Sold outHolders
Q3 202113,571$709.0K<0.1%+6,331+87.4%AddedHolders
Q2 20217,240$492.0K<0.1%+7,240NewHolders